Anxin Wang

Head of R&D Center at Hopstem

Experienced with iPSC/ESC culture and glia / neural differentiation. Dr. Wang has completed high-content and high-throughput screening of human glial cells and neurons derived from iPSC from Rett Syndrome patients at UWM. He leads the Hopstem R&D team to develop innovative iPSC cell products.

Links


Org chart


Teams


Offices

This person is not in any offices


Hopstem

Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.


Headquarters

Hangzhou, China

Employees

11-50

Links